All

Results: 3529-3540 of 67599

BioVersys and partners’ phase 2a tuberculosis trial results published in New England Journal of Medicine

Rio Tinto: Solid results underpinned by +8% CuEq production and sharper cost discipline

Lundin Mining Increases M&I Copper Mineral Resources by 37% and Updates Mineral Reserves

PR Newswire associated0

Supreme Courts of Singapore and Cambodia Sign Memorandum of Understanding for Judicial Cooperation

BSE (formerly Bombay Stock Exchange) Selects ITRS to Strengthen Real-Time Monitoring and Operational Resilience

Compass Pathways Announces Pricing of $150 Million Public Offering

PR Newswire associated0

David Topples Goliath: Non-League Flixton FC Stuns National League North Powerhouse Radcliffe FC

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM

Kantata Earns Spot on G2’s 2026 Best Software Awards for Project Management Products

GlobeNewswire associated0

Monument Mining Limited Recognized as Top 50 TSX Venture Company

Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Pershing Square Holdings Ltd. Releases 2025 Annual Financial Statements